Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus

Yasuji Arase, Fumitaka Suzuki, Mariko Kobayashi, Yoshiyuki Suzuki, Yusuke Kawamura, Naoki Matsumoto, Norio Akuta, Norihisa Imai, Masahiro Kobayashi, Hitomi Sezaki, Satoshi Saito, Tetsuya Hosaka, Kenji Ikeda, Hiromitsu Kumada, Yuki Ohmoto, Kazuhisa Amakawa, Hiroshi Tsuji, Shium Dong Hsieh, Tetsurou Kobayashi

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science